-
Posted: February 8th, 2019, 3:00pm GMT
Conditions: Glioblastoma Multiforme; Glioma of Brain
Interventions: Drug: Ribociclib; Drug: Everolimus 2.5 MG
Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; Ivy Brain Tumor Center; Barrow Neurological Institute
Recruiting
-
Posted: February 5th, 2019, 3:00pm GMT
Condition: Primary Brain Neoplasm
Interventions: Drug: Hyperpolarized Carbon C 13 Pyruvate; Procedure: Magnetic Resonance Spectroscopic Imaging
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: January 30th, 2019, 3:00pm GMT
Condition: Aneurysm, Cerebral
Intervention: Drug: Lidocaine
Sponsor: Clinical Hospital Centre Zagreb
Not yet recruiting
-
Posted: January 28th, 2019, 3:00pm GMT
Conditions: Brain Metastases, Adult; Radiotherapy
Interventions: Drug: AGuIX®; Radiation: Whole Brain Radiation Therapy
Sponsors: University Hospital, Grenoble; NH THERAGUIX
Not yet recruiting
-
Posted: January 24th, 2019, 3:00pm GMT
Condition: Pituitary Adenoma
Intervention: Diagnostic Test: PET imaging
Sponsors: Cardiff University; Cardiff and Vale University Health Board
Recruiting
-
Posted: January 17th, 2019, 3:00pm GMT
Conditions: Metastatic Breast Cancer; Brain Metastases
Interventions: Drug: Nivolumab; Radiation: Stereotactic Radiosurgery
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Bristol-Myers Squibb
Recruiting
-
Posted: January 16th, 2019, 3:00pm GMT
Condition: Acromegaly Due to Pituitary Adenoma
Interventions: Other: GIP-A; Other: Placebo
Sponsors: University of Copenhagen; Rigshospitalet, Denmark; Aarhus University Hospital; Aalborg Universitetshospital; Odense University Hospital; Herlev and Gentofte Hospital
Not yet recruiting
-
Posted: January 15th, 2019, 3:00pm GMT
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Estrogen Receptor Positive; HER2/Neu Negative; Metastatic Breast Carcinoma; Metastatic Malignant Neoplasm in the Brain; Postmenopausal; Prognostic Stage IV Breast Cancer AJCC v8
Interventions: Drug: Copanlisib; Drug: Fulvestrant
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: January 11th, 2019, 3:00pm GMT
Condition: NSCLC
Intervention: Drug: Apatinib
Sponsor: Hubei Cancer Hospital
Not yet recruiting
-
Posted: January 10th, 2019, 3:00pm GMT
Condition: NSCLC
Interventions: Drug: Anlotinib; Drug: Docetaxel; Drug: Carboplatin
Sponsors: Tongji Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting
-
Posted: December 20th, 2018, 3:00pm GMT
Conditions: Glioblastoma; Recurrent Glioblastoma; GBM; Recurrent GBM
Interventions: Drug: MN-166; Drug: Temozolomide
Sponsor: MediciNova
Recruiting
-
Posted: December 12th, 2018, 3:00pm GMT
Conditions: Pituitary Tumor; Surgery; Olfactory Nerve Injuries
Intervention: Procedure: Electrocautery versus scalpel
Sponsor: St. Michael's Hospital, Toronto
Not yet recruiting
-
Posted: December 6th, 2018, 3:00pm GMT
Conditions: Cancer; Melanoma (Skin); Melanoma, Uveal; Melanoma, Ocular; Bladder Cancer; Mismatch Repair Deficiency; Microsatellite Instability; Non-melanoma Skin Cancer
Interventions: Biological: RP1; Biological: nivolumab
Sponsor: Replimune Inc.
Recruiting
-
Posted: December 5th, 2018, 3:00pm GMT
Condition: Breast Cancer
Interventions: Drug: Trastuzumab; Drug: GDC-0084
Sponsors: Dana-Farber Cancer Institute; Kazia Therapeutics Limited
Recruiting
-
Posted: November 6th, 2018, 3:00pm GMT
Conditions: Brain Tumor Adult; Epilepsy
Intervention: Device: Wise Cortical Strip
Sponsors: Wise S.r.l.; Genae; Fondazione Don Carlo Gnocchi Onlus
Not yet recruiting
-
Posted: November 6th, 2018, 3:00pm GMT
Condition: Non Small Cell Lung Cancer Metastatic
Interventions: Drug: Temozolomide capsules; Device: radiotherapy
Sponsor: Taizhou Hospital
Not yet recruiting
-
Posted: October 4th, 2018, 2:00pm GMT
Condition: Breast Cancer Survivors
Interventions: Behavioral: Kirtan Kriya meditation; Behavioral: Music listening program
Sponsor: University of Texas at Austin
Recruiting
-
Posted: October 3rd, 2018, 2:00pm GMT
Condition: Metastatic Colon Cancer
Intervention: Device: Magnetic resonance imaging
Sponsor: Poitiers University Hospital
Recruiting
-
Posted: September 25th, 2018, 2:00pm GMT
Conditions: Glioma; Brain Tumor; Primary Brain Tumor; Malignant Glioma; Malignant Primary Brain Tumor
Intervention: Diagnostic Test: 3T MRI Scanner
Sponsor: University of Miami
Recruiting
-
Posted: September 21st, 2018, 2:00pm GMT
Conditions: Invasive Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain
Interventions: Procedure: Dynamic Susceptibility Contrast-MRI (DSC-MRI); Procedure: Magnetic Resonance Imaging (MRI)
Sponsor: Emory University
Recruiting
-
Posted: September 5th, 2018, 2:00pm GMT
Conditions: Glioblastoma Multiforme of Brain; Anaplastic Astrocytoma of Brain; Gliosarcoma of Brain
Intervention: Biological: C134
Sponsor: University of Alabama at Birmingham
Not yet recruiting
-
Posted: August 31st, 2018, 2:00pm GMT
Conditions: Leukemia; Brain Tumor; Solid Tumor; Lymphoma
Interventions: Drug: ALRN-6924; Drug: Cytarabine
Sponsors: Dana-Farber Cancer Institute; TeamConnor Childhood Cancer Foundation; Cookies for Kids' Cancer
Recruiting
-
Posted: August 8th, 2018, 2:00pm GMT
Condition: Intracranial Glioma
Interventions: Procedure: Awake Anesthesia Protocol; Procedure: Non-awake Anesthesia Protocol
Sponsor: Mayo Clinic
Not yet recruiting
-
Posted: August 7th, 2018, 2:00pm GMT
Condition: Breast Cancer
Interventions: Other: SAE battery; Behavioral: Assessments
Sponsors: Memorial Sloan Kettering Cancer Center; The City College of New York
Recruiting
-
Posted: August 6th, 2018, 2:00pm GMT
Conditions: Metastatic Breast Cancer With HER2 Positive; Triple Negative Breast Cancer
Intervention: Procedure: Brain MRI
Sponsor: Yonsei University
Not yet recruiting
-
Posted: July 19th, 2018, 2:00pm GMT
Condition: Pediatric Brain Tumor
Interventions: Procedure: Ketogenic diet; Drug: BCNU
Sponsor: Washington University School of Medicine
Not yet recruiting
-
Posted: July 3rd, 2018, 2:00pm GMT
Conditions: Cancer-related Problem/Condition; Exercise
Interventions: Behavioral: TEHE only; Behavioral: Auricular Point Acupressure; Behavioral: Mindfulness body scan
Sponsor: Johns Hopkins University
Not yet recruiting
-
Posted: June 25th, 2018, 2:00pm GMT
Conditions: Craniotomy; Hypertension
Interventions: Drug: Magnesium sulphate; Drug: Lidocaine Hydrochloride; Drug: Normal saline
Sponsor: Ahmed Mohamed ELbadawy
Recruiting
-
Posted: June 21st, 2018, 2:00pm GMT
Conditions: Malignant Central Nervous System Neoplasm; Metastatic Malignant Neoplasm in the Central Nervous System
Interventions: Other: Gadolinium; Drug: Hyperpolarized Carbon C 13 Pyruvate; Procedure: Magnetic Resonance Imaging; Procedure: Magnetic Resonance Spectroscopic Imaging
Sponsor: Daniel M. Spielman
Recruiting
-
Posted: May 24th, 2018, 2:00pm GMT
Conditions: NSCLC; Non-small Cell Lung Cancer
Intervention: Drug: Osimertinib
Sponsor: Case Comprehensive Cancer Center
Recruiting
-
Posted: May 18th, 2018, 2:00pm GMT
Conditions: Anaplastic Astrocytoma, IDH-Mutant; Diffuse Astrocytoma, IDH-Mutant; IDH1 Gene Mutation; IDH2 Gene Mutation
Interventions: Drug: Glutaminase Inhibitor CB-839 Hydrochloride; Other: Questionnaire Administration; Radiation: Radiation Therapy; Drug: Temozolomide
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: May 18th, 2018, 2:00pm GMT
Condition: Glioblastoma
Interventions: Drug: TN-TC11G; Drug: Temozolomide Oral Product; Radiation: Radiotherapy
Sponsors: Grupo Español de Investigación en Neurooncología; Medical Cannabis Bike Tour; Voices Against Brain Cancer; Tilray
Not yet recruiting
-
Posted: May 15th, 2018, 2:00pm GMT
Conditions: Brain Neoplasms; Adult Brain Tumor
Intervention: Diagnostic Test: PET imagery
Sponsor: Center Eugene Marquis
Recruiting
-
Posted: April 9th, 2018, 2:00pm GMT
Condition: Glioblastoma
Interventions: Biological: INO-5401; Biological: INO-9012; Biological: Cemiplimab; Radiation: Radiation Therapy; Drug: Temozolomide
Sponsor: Inovio Pharmaceuticals
Recruiting
-
Posted: March 23rd, 2018, 2:00pm GMT
Conditions: Glioblastoma; Radiotherapy; Complications; Cognitive Decline; Chemoradiation
Intervention: Drug: Ramipril
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting
-
Posted: February 16th, 2018, 3:00pm GMT
Conditions: Glioma; Glioma of Brain; Brain Tumor
Interventions: Drug: Lacosamide; Drug: Levetiracetam
Sponsor: Duke University
Recruiting
-
Posted: February 7th, 2018, 3:00pm GMT
Condition: Newly Diagnosed High Grade Glioma
Interventions: Drug: Temozolomide; Radiation: conformal brain radiation therapy; Drug: Nivolumab; Drug: Ipilimumab; Drug: Bevacizumab; Drug: Metronomic Temozolomide
Sponsor: John Wayne Cancer Institute
Recruiting
-
Posted: January 18th, 2018, 3:00pm GMT
Conditions: Lung Cancer; Brain Cancer
Interventions: Device: Siemens Somatom Definition Edge; Device: Philips Brilliance Big Bore CT/simulator
Sponsors: Washington University School of Medicine; National Cancer Institute (NCI)
Recruiting
-
Posted: September 8th, 2017, 2:00pm GMT
Condition: Brain Tumor
Intervention: Drug: Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine
Sponsors: University of Utah; Blue Earth Diagnostics
Recruiting
-
Posted: July 25th, 2017, 2:00pm GMT
Conditions: Non-Small Cell Lung Cancer; Small Cell Lung Cancer; Urothelial Carcinoma; Head and Neck Squamous Cell Carcinoma; Merkel Cell Carcinoma; Melanoma; Renal Cell Carcinoma; Gastric Cancer; Cervical Cancer; Hepatocellular Carcinoma; Microsatellite Instability; Mismatch Repair Deficiency; Colorectal Cancer
Interventions: Drug: ALT-803 + Pembrolizumab; Drug: ALT-803 + Nivolumab; Drug: ALT-803 + Atezolizumab; Drug: ALT-803 + Avelumab
Sponsor: Altor BioScience
Recruiting
-
Posted: July 18th, 2017, 2:00pm GMT
Condition: Solid Tumor
Interventions: Radiation: Stereotactic radiotherapy; Other: Biological: humanized anti-PD-1 monoclonal antibody; Other: Biological: humanized anti-PD-L1 monoclonal antibody
Sponsors: Virginia Commonwealth University; National Cancer Institute (NCI)
Recruiting
-
Posted: July 12th, 2017, 2:00pm GMT
Conditions: Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms; Sarcoma; Colorectal Neoplasms; Salivary Gland Neoplasms; Biliary Tract Neoplasms; Brain Neoplasm, Primary; Melanoma; Glioblastoma; Bile Duct Neoplasms; Astrocytoma; Head and Neck Squamous Cell Carcinoma; Pontine Glioma; Pancreatic Neoplasms; Ovarian Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma; Skin Carcinoma; Carcinoma, Bronchogenic; Bronchial Neoplasms; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms, Nerve Tissue; Nevi and Melanomas; Intestinal Neoplasms; Thyroid Cancer; GIST; Malignant Peripheral Nerve Sheath Tumors; Breast Secretory Carcinoma; Uterine Neoplasms; Fibrosarcoma; Infantile Fibrosarcoma; Congenital Mesoblastic Nephroma; Central Nervous System Neoplasms
Intervention: Drug: LOXO-195
Sponsors: Loxo Oncology, Inc.; Bayer
Recruiting
-
Posted: June 27th, 2017, 2:00pm GMT
Conditions: Breast Adenocarcinoma; HER2/Neu Positive; Recurrent Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7
Interventions: Drug: Atezolizumab; Other: Laboratory Biomarker Analysis; Drug: Paclitaxel; Biological: Pertuzumab; Other: Placebo; Other: Quality-of-Life Assessment; Biological: Trastuzumab
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: June 8th, 2017, 2:00pm GMT
Conditions: 1p/19q Co-deletion; Anaplastic Astrocytoma; Diffuse Astrocytoma; Glioma; IDH1 Gene Mutation; IDH2 Gene Mutation; Oligoastrocytoma; Oligodendroglioma; WHO Grade III Glioma
Interventions: Radiation: IMRT (Intensity-Modulated Radiation Therapy); Radiation: Proton Beam Radiation Therapy; Drug: Temozolomide
Sponsors: NRG Oncology; National Cancer Institute (NCI)
Recruiting
-
Posted: June 6th, 2017, 2:00pm GMT
Conditions: Tumor, Brain; Anesthesia, Local
Interventions: Drug: Lidocaine; Drug: Sodium chloride; Drug: Bupivacaine
Sponsor: Washington University School of Medicine
Not yet recruiting
-
Posted: June 5th, 2017, 2:00pm GMT
Conditions: Malignant Glioma of Brain; Glioblastoma
Intervention: Other: Palliative regimen consisting of LITT
Sponsors: Duke University; Monteris Medical
Recruiting
-
Posted: April 11th, 2017, 2:00pm GMT
Conditions: Glioblastoma; Gliosarcoma; Recurrent Glioblastoma; TP53 wt Allele; Unmethylated MGMT Gene Promoter
Interventions: Other: Laboratory Biomarker Analysis; Drug: MDM2 Inhibitor AMG-232; Other: Pharmacological Study; Radiation: Radiation Therapy
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: March 3rd, 2017, 3:00pm GMT
Condition: Pediatric Brain Tumor
Interventions: Biological: Personalized peptide vaccine; Drug: Poly ICLC; Procedure: Peripheral blood draw
Sponsor: Washington University School of Medicine
Not yet recruiting
-
Posted: February 13th, 2017, 3:00pm GMT
Conditions: Glioma; Glioblastoma; Glioblastoma Multiforme; GBM; Brain Cancer
Intervention: Drug: VAL-083 (Dianhydrogalactitol)
Sponsors: DelMar Pharmaceuticals, Inc.; Sun Yat-sen University
Recruiting
-
Posted: November 23rd, 2016, 3:00pm GMT
Conditions: EGFR Activating Mutation; EGFR NP_005219.2:p.T790M; Lung Carcinoma Metastatic in the Brain; Lung Non-Small Cell Carcinoma
Interventions: Biological: Bevacizumab; Other: Laboratory Biomarker Analysis; Drug: Osimertinib
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: September 21st, 2016, 2:00pm GMT
Conditions: Lymphoma; Neuroblastoma; Brain Tumor; Solid Tumor
Intervention: Drug: CUDC-907
Sponsors: Dana-Farber Cancer Institute; Curis, Inc.
Recruiting
-
Posted: April 1st, 2016, 2:00pm GMT
Conditions: Non-small Cell Lung Cancer; Brain Metastases
Interventions: Drug: Icotinib; Radiation: SRS; Drug: chemotherapy
Sponsor: Betta Pharmaceuticals Co., Ltd.
Recruiting
-
Posted: March 30th, 2016, 2:00pm GMT
Conditions: Glioblastoma Multiforme; Astrocytoma, Grade III; Anaplastic Ependymoma; Clear Cell Ependymoma; Ependymoma
Interventions: Biological: Heat Shock Protein Peptide Complex-96 (HSPPC-96); Procedure: Tumor Resection; Radiation: Radiation
Sponsors: Ann & Robert H Lurie Children's Hospital of Chicago; Northwestern University
Recruiting
-
Posted: March 24th, 2016, 2:00pm GMT
Conditions: Glioma; Glioblastoma; Glioblastoma Multiforme; GBM; Brain Cancer
Intervention: Drug: VAL-083, Dianhydrogalactitol
Sponsor: DelMar Pharmaceuticals, Inc.
Recruiting
-
Posted: March 23rd, 2016, 2:00pm GMT
Conditions: Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Neoplasm in the Spine; Stage IV Skin Melanoma
Interventions: Other: Laboratory Biomarker Analysis; Biological: Nivolumab; Radiation: Stereotactic Radiosurgery
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Accuray Incorporated
Recruiting
-
Posted: March 16th, 2016, 2:00pm GMT
Conditions: Astrocytoma, Grade IV; Giant Cell Glioblastoma; Glioblastoma Multiforme; Gliosarcoma
Intervention: Radiation: Radiation
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: January 20th, 2016, 3:00pm GMT
Conditions: Glioblastoma; Gliosarcoma; Recurrent Brain Neoplasm
Interventions: Biological: Anti-LAG-3 Monoclonal Antibody BMS 986016; Biological: Anti-PD-1; Other: Pharmacological Study; Other: Laboratory Biomarker Analysis; Biological: Anti-CD137
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI); Bristol-Myers Squibb
Recruiting
-
Posted: January 1st, 2016, 3:00pm GMT
Condition: Brain Neoplasms, Adult, Malignant
Intervention: Radiation: Stereotactic Radiosurgery
Sponsor: University of Texas Southwestern Medical Center
Recruiting
-
Posted: December 24th, 2015, 3:00pm GMT
Conditions: Epilepsy; Cancer; Brain Neoplasm
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting
-
Posted: December 18th, 2015, 3:00pm GMT
Conditions: Extensive Stage Small Cell Lung Carcinoma; Limited Stage Small Cell Lung Carcinoma
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy; Other: Cognitive Assessment; Radiation: Intensity-Modulated Radiation Therapy; Other: Laboratory Biomarker Analysis; Other: Quality-of-Life Assessment
Sponsors: NRG Oncology; National Cancer Institute (NCI); Radiation Therapy Oncology Group
Recruiting
-
Posted: November 20th, 2015, 3:00pm GMT
Condition: Brain Tumor
Intervention: Radiation: standard adjuvant local radiation therapy or cranial radiation therapy
Sponsor: Chang Gung Memorial Hospital
Recruiting
-
Posted: October 15th, 2015, 2:00pm GMT
Condition: Brain Metastases
Intervention: Radiation: brain metastatic patients
Sponsor: Istituto Clinico Humanitas
Recruiting
-
Posted: October 15th, 2015, 2:00pm GMT
Conditions: Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms; Sarcoma; Colorectal Neoplasms; Salivary Gland Neoplasms; Biliary Tract Neoplasms; Brain Neoplasm, Primary; Carcinoma, Ductal, Breast; Melanoma; Solid Tumors; Glioblastoma; Bile Duct Neoplasms; Astrocytoma; Head and Neck Squamous Cell Carcinoma; Pontine Glioma; Pancreatic Neoplasms; Ovarian Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma; Carcinoma; Carcinoma, Bronchogenic; Bronchial Neoplasms; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms, Nerve Tissue; Nevi and Melanomas
Intervention: Drug: Larotrectinib LOXO-101
Sponsors: Bayer; Loxo Oncology, Inc.
Recruiting
-
Posted: September 30th, 2015, 2:00pm GMT
Conditions: Pediatric Solid Tumor; Refractory Tumor; Recurrent Tumor; CNS Malignancies
Intervention: Drug: Ramucirumab
Sponsors: Eli Lilly and Company; Children's Oncology Group
Recruiting
-
Posted: May 13th, 2015, 2:00pm GMT
Conditions: Brain Tumor, Recurrent; Brain Tumor, Refractory
Intervention: Biological: HER2-specific T cells
Sponsors: Baylor College of Medicine; The Methodist Hospital System; Center for Cell and Gene Therapy, Baylor College of Medicine; Texas Children's Hospital
Recruiting
-
Posted: March 18th, 2015, 2:00pm GMT
Conditions: Metastatic Brain Tumor; Primary Brain Tumor
Intervention: Device: NeuroBlate System
Sponsor: Monteris Medical
Recruiting
-
Posted: December 1st, 2014, 3:00pm GMT
Conditions: Malignant Glioma; Brain Tumor, Recurrent
Intervention: Drug: D2C7-IT
Sponsor: Darell D. Bigner, MD, PhD
Recruiting
-
Posted: July 1st, 2014, 2:00pm GMT
Conditions: Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma
Interventions: Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy; Radiation: photon beam radiation therapy; Radiation: proton beam radiation therapy; Drug: temozolomide; Other: laboratory biomarker analysis
Sponsors: NRG Oncology; National Cancer Institute (NCI); Radiation Therapy Oncology Group
Recruiting
-
Posted: April 2nd, 2014, 2:00pm GMT
Conditions: Anaplastic Astrocytoma; Anaplastic Ependymoma; Anaplastic Oligodendroglioma; Gliosarcoma; Mixed Glioma; Recurrent Adult Brain Neoplasm; Recurrent Glioblastoma
Interventions: Other: Laboratory Biomarker Analysis; Drug: Lapatinib Ditosylate; Other: Pharmacological Study; Procedure: Therapeutic Conventional Surgery
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: July 3rd, 2013, 2:00pm GMT
Condition: Tumors Metastatic to Brain
Interventions: Radiation: radiosurgery; Procedure: therapeutic conventional surgery; Procedure: quality-of-life assessment
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: March 30th, 2012, 2:00pm GMT
Conditions: Glioma; Glioblastoma Multiforme; Neoplasms
Interventions: Procedure: Surgery; Drug: Chemotherapy; Radiation: Radiotherapy; Biological: DC vaccination; Drug: blank placebo
Sponsors: Huashan Hospital; Fudan University
Recruiting
-
Posted: January 6th, 2012, 3:00pm GMT
Conditions: Ewing's Family Tumors; Renal Tumors; Hepatoblastoma; Rhabdomyosarcoma; Soft Tissue Sarcoma; Primary Malignant Brain Neoplasms; Retinoblastoma; Medulloblastoma; Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET); Atypical Teratoid/Rhabdoid Tumor (AT/RT); CNS Tumors; Germ Cell Tumors
Interventions: Drug: Ifosfamide; Drug: Etoposide; Drug: Mesna; Biological: G-CSF; Drug: Busulfan; Drug: Melphalan; Drug: Thiotepa; Biological: Autologous stem cell infusion; Radiation: Radiation; Drug: Carboplatin; Drug: Paclitaxel; Procedure: Leukapheresis; Drug: Anti-seizure prophylaxis; Drug: Ursodiol
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting
-
Posted: December 19th, 2011, 3:00pm GMT
Condition: Breast Cancer
Interventions: Drug: HKI-272; Procedure: Surgical Resection; Drug: Capecitabine; Drug: Ado-Trastuzumab Emtansine
Sponsors: Dana-Farber Cancer Institute; Translational Breast Cancer Research Consortium; Puma Biotechnology, Inc.
Recruiting
-
Posted: October 3rd, 2011, 2:00pm GMT
Conditions: Brain Metastasis; Cancer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: March 18th, 2010, 2:00pm GMT
Conditions: Low Grade Glioma; Recurrent Childhood Pilocytic Astrocytoma; Recurrent Neurofibromatosis Type 1; Recurrent Visual Pathway Glioma; Refractory Neurofibromatosis Type 1; Refractory Visual Pathway Glioma
Interventions: Other: Laboratory Biomarker Analysis; Other: Pharmacological Study; Drug: Selumetinib
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: April 23rd, 2009, 2:00pm GMT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: concomitant temozolomide (TMZ); Radiation: radiotherapy; Drug: procarbazine; Drug: adjuvant temozolomide (TMZ); Drug: CCNU; Drug: vincristine
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); European Organisation for Research and Treatment Center (EORTC); Canadian Cancer Trials Group
Recruiting
-
Posted: December 18th, 2008, 3:00pm GMT
Condition: Brain Tumors
Intervention: Procedure: Tissue Bank
Sponsor: University of Florida
Recruiting
-
Posted: January 23rd, 2008, 3:00pm GMT
Condition: Pituitary Tumor
Intervention:
Sponsor: Cedars-Sinai Medical Center
Recruiting
-
Posted: September 23rd, 2002, 2:00pm GMT
Conditions: Xeroderma Pigmentosum; Melanoma; Squamous Cell Carcinoma; Basal Cell Carcinoma; Skin Cancer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting